Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders. (Q46663603)
Jump to navigation
Jump to search
scientific article published on 22 August 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders. |
scientific article published on 22 August 2005 |
Statements
Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders (English)
F Aubey
D Schlemmer
J P N Ruiter
R J A Wanders
22 August 2005